VAERS reports by lot

Merck HPV lot T029522: VAERS reports

24 VAERS reports list lot T029522 as a Merck HPV vaccine, received between 2021-07-21 and 2023-04-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1032%
Gastrointestinal723%
Musculoskeletal310%
General / Systemic (non-local)310%
Cardiac / Cardiovascular26%
Allergic / Anaphylactic26%
Dermatological (non-injection-site)26%
Psychiatric / Neuropsychiatric13%
Injection-site / Local reaction13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan8
Colorado3
Illinois2
Wisconsin2
Washington2
District of Columbia1
West Virginia1
South Carolina1
Kansas1
Texas1
Louisiana1
North Carolina1

Reports by month received

2021-072
2021-086
2021-098
2021-102
2022-092
2022-101
2023-032
2023-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.